CD73 expression is increased in several types of cancer [183] and is associated with poor prognosis in patients with high grade serous ovarian cancer [119], leading Sociali et al. to investigate the effect of blocking both NAMPT and CD73 in an ovarian cancer mouse model [156]. Here, NAMPT is linked to ovarian carcinoma.